RxDoctor Payments Data

Lauren Bechtold, MD

Plastic and Reconstructive Surgery · Boise, IDNPI 1619498821

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (36.8%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Trice Medical, Inc. at 30.8% of the total. Reporting peaked in 2021 at $1,699 and has fallen 97.8% since, to $37 in 2024.

$4,539in general payments, 2019–2025

Across 27 payments — averaging $168.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Trice Medical, Inc.$1K
  • Medical Device Business Services, Inc.$960
  • Elite Orthopedics, LLC$711
  • Acera Surgical, Inc.$335
  • Integra Lifesciences Corporation$300
  • Baxter Healthcare$218
  • plus $615 from 6 others

What the payments were for

  • Consulting fees$1,35030%
  • Speaking & faculty fees$501%
  • Food & beverage$1,46832%
  • Education$1,67137%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic and reconstructive surgery providers in Idahoto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$80,143
Medicare patients
180
Services billed
639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ondansetron OdtOndansetron13$87
Oxycodone Hcl29$64
Tramadol Hcl36$45

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →